Status:
UNKNOWN
Effectiveness of BP Remote Monitoring With Virtual Physician Management in Hypertensive Patients.
Lead Sponsor:
AIRx Health, Inc.
Collaborating Sponsors:
Stanford University
Conditions:
Hypertension
Stroke (CVA) or TIA
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To assess the feasibility and adoptability of DailyDoctor's remote monitoring clinical decision support software tool in helping physicians virtually manage systolic blood pressures among patients wit...
Detailed Description
To assess the feasibility and adoptability of DailyDoctor's remote monitoring clinical decision support software tool in helping physicians virtually manage systolic blood pressures among patients wit...
Eligibility Criteria
Inclusion
- Age 18 years or older. A history of ischemic or hemorrhagic stroke, or transient ischemic attack. The ability to report blood pressure values by phone (either a patient or designated caregiver may call to report values).
- At least 2 BP measurements that are ≥140 mmHg systolic or ≥90 mmHg diastolic obtained on different days in the last 6 months in any setting (including at home, in clinic, or in the hospital setting).
- The referring physician feels the patient would benefit from BP optimization. Consent to receive care from telehealth physicians available through the DailyDoctor monitoring platform.
- English or Spanish speaking.
Exclusion
- Currently enrolled in another interventional research study Inability to comply with study protocol Have a planned surgical procedure during the study period Upper arm circumference \> 20 inches Has diagnosis of end-stage renal disease (GFR \< 15 mL/min), Serum creatinine \> 2.0 mg/dL (176.8 μmol/L), or currently undergoing dialysis treatment (10) Women who are pregnant or who are planning to become pregnant during the study period.
- Blood pressure reduction is not indicated (e.g. patients who have a high blood pressure target to augment cerebral perfusion).
- Any other reason that, in the opinion of the investigator, makes the person a poor candidate for participation in this study
Key Trial Info
Start Date :
April 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2023
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05319418
Start Date
April 1 2022
End Date
March 1 2023
Last Update
April 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford Stroke Center
Stanford, California, United States, 94304